newsfilter
← Latest News
GlobeNewswire·

YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute

  • YD Bio Limited (NASDAQ: YDES) published a peer-reviewed review article in the journal Nutrients on August 19, 2026.
  • The article, titled "Beyond Bone Health: Exploring the 'Heart–Brain–Bone' Axis Modulated by Lipid-Soluble Nutrients," examines the roles of omega-3 fatty acids, vitamin D3, & vitamin K2 across cardiovascular, neurological, & skeletal systems.
  • The research was co-authored by YD Bio's scientific team alongside physicians from the Taiwan Chronic Disease Healthcare Association, the Future Health Institute, & Taipei Medical University Hospital.
  • This publication follows an August 11, 2026 announcement regarding YD Bio's physician-partnership initiative & the launch of two nutraceutical products in Taiwan.
  • The manuscript was submitted on August 11, 2026, accepted on August 18, 2026, & published the following day as an open-access article.
  • The study integrates evidence on calcium trafficking, inflammation resolution, & vascular integrity to address aging-related conditions including cardiovascular disease, neurocognitive decline, & osteoporosis.
  • YD Bio's physician-partnership model combines clinical observations from practicing doctors with company-led product development, sourcing, & commercialization.
  • Founder & CEO Dr. Ethan Shen stated the publication validates the company's strategy of supporting consumer health products with scientific rigor & peer-reviewed literature.
  • The article is a narrative review of existing literature & does not report new experimental or clinical data regarding product safety or efficacy.
  • YD Bio intends to continue supporting peer-reviewed work & expanding its physician-partnership model with additional healthcare professionals & organizations.